Page 22 - Genomic Medicine in Emerging Economies

References 11

Medicine Alliance (www.genomicmedicinealliance.org; see Chapter 10) or the
Global Genomic Medicine Collaborative (www.g2mc.org) have already been
formed, providing several successful examples from the very early years of their
establishment, and demonstrating the tangible benefits that can arise from
international cooperation and synergies among developing nations in order to
achieve better health outcomes.
We strongly believe that the examples of successful implementation of genomic
medicine described in this book, although not exhaustive, could serve as exam-
ples to be readily replicated in other countries, such as in the Middle East and
Europe (Balkan and Eastern European countries), with a view of expediting
their transition to genomic medicine by harmonizing their strategies and poli-
cies with those of various other national health care systems that already enjoy
the tangible benefits of genomics. Clearly, the inclusion of other omics disci-
plines (e.g., proteomics, transciptomics, epigenomics, metabolomics, etc.) into
precision medicine will further contribute to these developments.

Acknowledgment

We thank all the authors of the chapters of this book for their contributions, highlighting the im-
portance of implementing genomic medicine in developing nations.

References

Alvarez, C., Tapia, T., Perez-Moreno, E., Gajardo-Meneses, P., Ruiz, C., Rios, M., Missarelli, C.,
Silva, M., Cruz, A., Matamala, L., Carvajal-Carmona, L., Camus, M., Carvallo, P., 2017. BRCA1
and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast
cancer families in Chile. Oncotarget 8 (43), 74233–74243.
Bohra, A, Pandey, M.K., Jha, U.C., Singh, B., Singh, I.P., Datta, D., Chaturvedi, S.K., Nadarajan,
N., Varshney, R.K., 2014. Genomics-assisted breeding in four major pulse crops of developing
countries: present status and prospects. Theor. Appl. Genet. 127 (6), 1263–1291.
Christy, J., 2017. Top Emerging Market Economies in the Global Economy. Available from: https://
www.thebalance.com/top-emerging-market-economies-1979085.
Coles, E., Mensah, G.A., 2017. Geography of genetics and genomics research funding in Africa.
Glob. Heart 12 (2), 173–176.
Cooper, D.N., Brand, A., Dolzan, V., Fortina, P., Innocenti, F., Michael Lee, M.T., Macek, Jr., M.,
Al-Mulla, F., Prainsack, B., Squassina, A., Vayena, E., Vozikis, A., Williams, M.S., Patrinos, G.P.,
2014. Bridging genomics research between developed and developing countries: the genomic
medicine alliance. Pers. Med. 11 (7).
Forero, D.A., Wonkam, A., Wang, W., Laissue, P., López-Correa, C., Fernández-López, J.C., Mu-
gasimangalam, R., Perry, G., 2016. Current needs for human and medical genomics research
infrastructure in low and middle income countries. J. Med. Genet. 53 (7), 438–440.
Gatt, J.M., Burton, K.L., Williams, L.M., Schofield, P.R., 2015. Specific and common genes implicat-
ed across major mental disorders: a review of meta-analysis studies. J. Psychiatr. Res. 60, 1–13.
Hindorff, L.A., Bonham, V.L., Brody, L.C., Ginoza, M.E.C., Hutter, C.M., Manolio, T.A., Green,
E.D., 2017. Prioritizing diversity in human genomics research. Nat. Rev. Genet.